Raising the Price on This Heart Health Pharma
An approved plan for a second Phase 3 trial could spell big upward movement for one of our positions. And while we wait and see, we’re upping the buy up-to position. Take action today if you haven’t already!
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.